Showing results (191-200 of 261) with videos related to
Sort By:
Pageof 27
Cancer|October 15, 1985
Treatment of unresectable or metastatic osteosarcoma with cisplatin or cisplatin-doxorubicinC B Pratt, J E Champion, N Senzer, et al.National Cancer Institute Monograph|April 1, 1981
Treatment of childhood rhabdomyosarcoma at St. Jude Children's Research Hospital, 1962--78C B Pratt, H O Hustu, A P Kumar, et al.Cancer Treatment Reports|April 1, 1985
Phase I trial of mitoxantrone in childrenR S Ungerleider, C B Pratt, T J Vietti, et al.Cancer Research|March 1, 1987
Potentiation of ifosfamide neurotoxicity, hematotoxicity, and tubular nephrotoxicity by prior cis-diamminedichloroplatinum(II) therapyM P Goren, R K Wright, C B Pratt, et al.Medical and Pediatric Oncology|January 1, 1991
Concept of maximum tolerated systemic exposure and its application to phase I-II studies of anticancer drugsW E Evans, J H Rodman, M V Relling, et al.Pediatric Hematology and Oncology|September 1, 1994
Outcome for patients with constitutional 13q chromosomal abnormalities and retinoblastomaC B Pratt, S C Raimondi, S C Kaste, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1984
The effect of prior cisplatin therapy on the pharmacokinetics of high-dose methotrexateW R Crom, C B Pratt, A A Green, et al.Cancer|March 15, 1992
Carcinoembryonic antigen and carbohydrate 19-9 antigen as markers for colorectal carcinoma in children and adolescentsC A Angel, C B Pratt, B N Rao, et al.AJR. American Journal of Roentgenology|August 1, 1990
Use of MR imaging to assess results of chemotherapy for Ewing sarcomaM A Lemmi, B D Fletcher, N M Marina, et al.Medical and Pediatric Oncology|April 1, 1996
Role of irradiation in management of synovial sarcoma: St. Jude Children's Research Hospital experienceJ Fontanesi, A S Pappo, D M Parham, et al.Pageof 27